원료의약품
Topiramate (토피라메이트)
KDMF APIs
Topiramate
품목명 (한글) | 토피라메이트 |
|---|---|
분류 | 중추신경계 |
CAS No. | 97240-79-4 |
KDMF 등록번호 | 20130912-170-I-365-10(2) 20160713-170-I-472-16(1) |
제조원 | Bal Pharma Limited Nifty Labs Pvt.,Ltd. |
규격 | USP |
품목 정보
IUPAC Name | [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0²,⁶]dodecan-6-yl]methyl sulfamate |
|---|---|
Synonyms | 2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate 2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate |
Description | Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines. It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults. Since 2012, the extended-release formulation has been approved in combination with phentermine for chronic weight management therapy in adults. Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen. Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug |
Certificate of Analysis | If you need more information, please contact us. |
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신드립니다. (02-579-1056 · ace@acebiopharm.com)